SYMMETRY MEDICAL CHELTENHAM LIMITEDActive

Company number 03418253Private limited companyIncorporated 1997

Key figures

£23,501,000-17.6%
Net assets 2025
-17.6%
Average annual change 2022–2025
010 m20 m30 m20222025

SYMMETRY MEDICAL CHELTENHAM LIMITED does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.

Ratios

2025
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
010 m20 m30 m20222025
Filed accounts2022–2025
20222025
Turnover0—
Profit for the year—891,000
Total assets——
Total liabilities665,406665,000
Net assets / total equity28,516,59423,501,000
Average number of employees00

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2025

The principal activity of the group is the manufacture of finished precision components in complex alloys principally for the world-wide orthopaedic and aerospace industries. The principal activity of the company is a holding company.

As described in the company's latest filed accounts.

Summary: SYMMETRY MEDICAL CHELTENHAM LIMITED

Company

SYMMETRY MEDICAL CHELTENHAM LIMITED is a private limited company registered with Companies House under company number 03418253. It was incorporated on 12 Aug 1997. Its status is active. The registered office is in Sheffield (S6). Its nature of business (SIC 2007) is activities of production holding companies (64202).

Accounts

The latest accounts in the database are for 2025 (period ending 27 Dec 2025); the company files group accounts. Profit for the year was £891,000. Net assets were £23,501,000, down 17.6% on the previous year. The company had an average of 0 employees. Figures are available for 2 financial years (2022–2025).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 28 Sep 2027. The next confirmation statement is due by 31 Mar 2027.